Brief: Valbiotis Signs Exclusive Agreement With ADECAL-Technopole And IFREMER

Valbiotis SA

24/09/2021 06:36

Sept 24 (Reuters) - Valbiotis SA  ALVAL.PA :
    * VALBIOTIS CONSOLIDATES ITS DEVELOPMENT OF INNOVATIVE
NATURAL
HEALTH SOLUTIONS BY INTEGRATING THE EXPLORATION OF MICROALGAE
PRODUCED IN NEW CALEDONIA, THROUGH AN EXCLUSIVE AGREEMENT WITH
ADECAL-TECHNOPOLE AND IFREMER
    * A LAUNCH OF IN VITRO AND IN VIVO EXPLORATIONS FROM AUTUMN
2021
AT VALBIOTIS RESEARCH AND DEVELOPMENT PLATFORM IN RIOM (63)
    * NO IMPACT ON VALBIOTIS' CASH FLOW HORIZON (H1 2024)
    * A CO-DEVELOPMENT FINANCED IN EQUAL PARTS
    * A BANK OF MICROALGAE STRAINS HAS ALREADY BEEN SELECTED AND
WILL
BE SCALED UP AND PRODUCED INDUSTRIALLY IN NEW CALEDONIA IN
RACEWAYS

Source text for Eikon:  ID:nBw6jH9zka 
Further company coverage:  ALVAL.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))